The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model
Open accessAbstract
BACKGROUND: Malaria transmission has declined substantially in the 21st century, but pregnant women in areas of sustained transmission still require protection to prevent the adverse pregnancy and birth outcomes associated with malaria in pregnancy (MiP). A recent call to action has been issued to address the continuing low coverage of intermittent preventive treatment of malaria in pregnancy (IPTp). This call has, however, been questioned by some, in part due to concerns about resistance to sulphadoxine-pyrimethamine (SP), the only drug currently recommended for IPTp. METHODS AND FINDINGS: Using an existing mathematical model of MiP, we combined estimates of the changing endemicity of malaria across Africa with maps of SP resistance mutations and current coverage of antenatal access and IPTp with SP (IPTp-SP) across Africa. Using estimates of the relationship between SP resistance mutations and the parasitological efficacy of SP during pregnancy, we estimated the varying impact of IPTp-SP across Africa and the incremental value of enhancing IPTp-SP uptake to match current antenatal care (ANC) coverage. The risks of MiP and malaria-attributable low birthweight (mLBW) in unprotected pregnancies (i.e., those not using insecticide-treated nets [ITNs]) leading to live births fell by 37% (33%-41% 95% credible interval [crI]) and 31% (27%-34% 95% crI), respectively, from 2000 to 2015 across endemic areas in sub-Saharan Africa. However, these gains are fragile, and coverage is far from optimal. In 2015, 9.5 million (8.3 million-10.4 million 95% crI) of 30.6 million pregnancies in these areas would still have been infected with Plasmodium falciparum without intervention, leading to 750,000 (390,000-1.1 million 95% crI) mLBW deliveries. In all, 6.6 million (5.6 million-7.3 million 95% crI) of these 9.5 million (69.3%) pregnancies at risk of infection (and 53.4% [16.3 million/30.6 million] of all pregnancies) occurred in settings with near-perfect SP curative efficacy (>99%) based on the most recent estimates of resistance. Forty-four percent of these pregnancies (23% of all pregnancies) were not receiving any IPTp-SP despite making ≥3 ANC visits, representing 160,000 (94,000-236,000 95% crI) preventable low birthweight (LBW) deliveries. Only 4% (1.4 million) of pregnancies occurred in settings with >10% prevalence of the sextuple haplotype associated with compromised SP effectiveness. Forty-two percent of all pregnancies occurred in settings where the quintuple dhfr/dhps haplotype had become established but where in vivo efficacy data suggest SP maintains the majority of its effectiveness in clearing infections. Not accounting for protection from the use of ITNs during pregnancy, expanding IPTp-SP to all women with ≥3 ANC visits in Africa could prevent an additional 215,000 (128,000-318,000 95% crI) LBW deliveries. In 26 countries with sufficient recent data to estimate ITN impact (population-based ITN usage data that can be stratified by gravidity), we estimate that, due primarily to low ITN use by primigravidae, only 16.5% of the potential LBW births prevented by scaling up IPTp-SP would in fact have already have been prevented through ITN use. Our analysis also highlights the difficulties associated with estimating the relationship between the effectiveness of interventions against parasitological endpoints such as placental infection at delivery and health outcomes including birthweight, which is also determined by a wide range of unrelated factors. We also did not capture other aspects of malaria burden such as clinical malaria, maternal and neonatal anaemia, and miscarriage, all of which increase the overall importance of effective preventative strategies but have their own relationship with transmission intensity, parity, and SP resistance. CONCLUSIONS: Despite recent declines in malaria transmission in Africa, the burden of MiP in the absence of adequate prevention remains substantial. Even accounting for SP resistance, extending IPTp-SP to all women attending ANC, as well as long-lasting insecticidal net distribution targeted towards first-time mothers, would have a sizeable impact upon maternal and infant health in almost all malaria-endemic settings in sub-Saharan Africa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig 2 Impact of IPTp-SP upon low birthweight and effect of resistance. (A) Comparison between modelled (lines) and observed (circles with bars indicating 95% confidence intervals) 28- and 42-d failure rates in different resistance settings. Solid lines show a setting where the original prevalence at first ANC visit was 45% (replicating the high transmission settings in which these data were collected) [22]. The dashed green line shows a model simulation from a setting with 20% prevalence at first ANC visit (to reflect the relatively lower prevalence setting of Mansa, Zambia [22]). Prophylaxis in the model is assumed to last for an average duration of 28 d (low quintuple mutation), 14 d (intermediate quintuple mutation), and 7 d (high quintuple mutation). Recrudescent infections (estimated by the PCR-corrected failure rate, not shown) were assumed to reappear uniformly throughout the observation period. (B) Example simulations of placental prevalence by week of gestation in the absence of intervention, and where sulphadoxine-pyrimethamine is given at 17, 25, and 32 wk gestation at the different levels of resistance. (C) How efficacy of IPTp-SP against LBW is assumed to vary by resistance category and transmission intensity (based on changes in the estimated average time spent infected). ANC, antenatal care; IPTp-SP, intermittent preventive treatment of malaria in pregnancy with sulphadoxine-pyrimethamine; LBW, low birthweight.](https://figures.cochat.ai/paper-figures/b734f69bfa374e0ea73597092fb98dfa/estimated-impact-on-birth-weight-of-scaling-up-intermittent-preventive-treatment-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Despite the clinically proven advantages of intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP), utilisation has been low in many African countries.”
From High uptake of Intermittent Preventive Treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“P. falciparum infection (either microscopically or sub-microscopically) during pregnancy is one of the major factors underlying low birth weight”
From High uptake of Intermittent Preventive Treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana (2019) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“several studies have shown the beneficial effect of IPTp-SP on the birth weight with some indication of a dose-dependent relationship with birth weight13,16,22”
From High uptake of Intermittent Preventive Treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana (2019) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., Dalrymple, U., Battle, K. E., Moyes, C. L., Henry, A., Eckhoff, P. A., et al. (2015) · Nature · doi:10.1038/nature15535 · Cited by 3,225 · cited 4×
“Published estimates of changes in the prevalence of malaria in children aged 2–10 y between 2000 and 2015 (estimated using a spatiotemporal geostatistical model fitted to geolocated prevalence data from 27,573 population clusters between 1994 and 2014) were obtained from the Malaria Atlas Project (MAP) at a 1 km × 1 k…”
BackgroundMethodInfluentialEpidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432
The burden of malaria in pregnancy in malaria-endemic areas
Steketee, R., Nahlen, B., Parise, M., & Menendez, C. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.28 · Cited by 1,063
Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa
Guyatt, H. L., & Snow, R. W. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.760-769.2004 · Cited by 458
Parise, M. E., Ayisi, J. G., Nahlen, B. L., Schultz, L. J., Roberts, J. M., Misore, A., Muga, R., Oloo, A. J., & Steketee, R. W. (1998) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1998.59.813 · Cited by 388
O. ter Kuile, F., van Eijk, A. M., & Filler, S. J. (2007) · JAMA · doi:10.1001/jama.297.23.2603 · Cited by 355
Kayentao, K., Garner, P., Maria van Eijk, A., Naidoo, I., Roper, C., Mulokozi, A., MacArthur, J. R., Luntamo, M., Ashorn, P., Doumbo, O. K., et al. (2013) · JAMA · doi:10.1001/jama.2012.216231 · Cited by 298
Eisele, T. P., Larsen, D. A., Anglewicz, P. A., Keating, J., Yukich, J., Bennett, A., Hutchinson, P., & Steketee, R. W. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70222-0 · Cited by 253
Mapping ‘partially resistant’, ‘fully resistant’, and ‘super resistant’ malaria
Naidoo, I., & Roper, C. (2013) · Trends in Parasitology · doi:10.1016/j.pt.2013.08.002 · Cited by 228
Schultz, L. J., Steketee, R. W., Macheso, A., Kazembe, P., Chitsulo, L., & Wirima, J. J. (1994) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1994.51.515 · Cited by 214
Research works printed but not linked: 2
- Njagi JK. The effects of sulfadoxine-pyrimethamine intermittent treatment and pyrethroid impregnated bed nets on malaria morbidity and birth weight in Bondo district, Kenya [dissertation]. Nairobi: University of Nairobi; 2002.
- PGT Walker, 2014, Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study, Lancet Glob Heal, 2, e460, 10.1016/S2214-109X(14)70256-6 · DOI
Cited by
Quakyi, I., Tornyigah, B., Houze, P., Kusi, K. A., Coleman, N., Escriou, G., Laar, A., Cot, M., Fobil, J., Asare, G. Q., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55046-5 · Cited by 183
Prevention of malaria in pregnancy
Desai, M., Hill, J., Fernandes, S., Walker, P., Pell, C., Gutman, J., Kayentao, K., Gonzalez, R., Webster, J., Greenwood, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30064-1 · Cited by 153
Self-citationOkell, L., Griffin, J. T., & Roper, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-06708-9 · Cited by 106
Chloroquine and Sulfadoxine–Pyrimethamine Resistance in Sub-Saharan Africa—A Review
Roux, A. T., Maharaj, L., Oyegoke, O. O., Akoniyon, O. P., Adeleke, M. A., Maharaj, R., & Okpeku, M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.668574 · Cited by 113
Huijben, S., & Paaijmans, K. P. (2017) · Evolutionary Applications · doi:10.1111/eva.12530 · Cited by 80
Metadata
- Authors
- Walker, P. G. T., Floyd, J., ter Kuile, F., & Cairns, M.
- Affiliations
- Imperial College London (GB)
- Corresponding author
- Walker, Patrick G. T.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-02-28
- Volume
- 14
- Issue
- 2
- Pages
- e1002243
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5330448
- OpenAlex
- W2593801067
- Cited by
- 73
- References
- 42
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 12 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 7 · 2017: 9
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Greater South Information System
- Funders
- Medical Research Council
- Department for International Development
- European and Developing Countries Clinical Trials Partnership
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- malaria in pregnancy, intermittent preventive treatment in pregnancy, sulfadoxine-pyrimethamine resistance, Plasmodium falciparum, low birth weight, antenatal care coverage, IPTp uptake, malaria endemicity, insecticide-treated nets, sub-Saharan Africa
- MeSH terms
- Antimalarials, Birth Weight, Child, Child, Preschool, Drug Combinations, Female, Humans, Malaria, Models, Theoretical, Pregnancy, Pyrimethamine, Sulfadoxine, Africa South of the Sahara, Drug Resistance, Multiple
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. https://app.cochat.ai/papers/10.1371/journal.pmed.1002243
- The paper
- Walker, P. G. T., Floyd, J., ter Kuile, F., & Cairns, M. (2017). Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002243
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.